✦ LIBER ✦

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

✍ Scribed by Abajo, A; Rodriguez, J; Bitarte, N; Zarate, R; Boni, V; Ponz, M; Chopitea, A; Bandres, E; Garcia-Foncillas, J

Book ID: 110000691
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 333 KB
Volume: 103
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605908

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin, irinotecan and capecitabine

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

✍ Zarate, R; Rodríguez, J; Bandres, E; Patiño-Garcia, A; Ponz-Sarvise, M; Viudez, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 352 KB

Dose finding study of erlotinib combined

Dose finding study of erlotinib combined to capecitabine and irinotecan in pretreated advanced colorectal cancer patients

✍ Emilio Bajetta; Maria Di Bartolomeo; Roberto Buzzoni; Erminia Ferrario; Katia F. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 275 KB

A phase 1 study of fixed dose rate gemci

A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer

✍ Weijing Sun; Maureen R. Hewitt; Marry R. Theobald; Diane Hershock; Daniel G. Hal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND. The combination of a fixed dose rate (FDR) infusion of gemcitabine and irinotecan may have a synergistic effect in the treatment of patients with advanced and metastatic pancreatic and biliary cancer. The current study was conducted to determine the dose‐limiting toxicit

A dose finding and pharmacokinetic study

A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer

✍ Lorenzo Fornaro; G. Masi; S. Bursi; F. Loupakis; E. Vasile; A. Antonuzzo; S. Chi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 273 KB

A phase II study of capecitabine, irinot

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

Fixed-dose rate infusion and standard ra

Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials

✍ Man-Tang Qiu, Xiang-Xiang Ding, Jing-Wen Hu… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 418 KB